Egdane, Filomena A.
HRN: 25-58-93 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/21/2024
CEFTAZIDIME 1GM (VIAL)
08/21/2024
08/28/2024
IV
1g
Q8h
Nonhealing Wound
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes